Medicine, Science, Public Health Must Merge For The Greater Good

My own background in schools of medicine and institutions for biomedical research perhaps leads me to stress the opportunities for those disciplines to impact research and education at schools of public health. While the agenda of such schools has turned more and more to hospital administration and the rationalization of the health-care system, this must not be to the neglect of using science for the most effective population-based measures to protect public health. These measures will be larg

Written byJoshua Lederberg
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

My own background in schools of medicine and institutions for biomedical research perhaps leads me to stress the opportunities for those disciplines to impact research and education at schools of public health. While the agenda of such schools has turned more and more to hospital administration and the rationalization of the health-care system, this must not be to the neglect of using science for the most effective population-based measures to protect public health. These measures will be largely, not exclusively, in the preventive sphere (T. Hancock, M. Garrett, Futures, 27:935-51, 1995). However, the typical separation of schools of public health and medicine has left a major gap in the scientific education and social sensitization of both groups.

In 1988, the Institute of Medicine (IOM) conducted a study called "The Future of Public Health," chaired by the late Richard Remington, a professor of public health at the University of Iowa. It ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies